The latest addition, a new API facility in Morrisville, North Carolina, will produce key components for solid dosage tablets, capsules, and RNA therapeutics
The initiative pairs consumer engagement with a public health message about prevention and early detection
Health innovations are viewed more positively than food and agricultural technologies
The results signal shift beyond paclitaxel-coated balloon (PCB) angioplasty in femoropopliteal artery disease
The submission is backed by positive results from the Phase 3 AFFIRM study
The move brings one of the country’s most widely prescribed blood thinners onto Cost Plus Drug Company’s online pharmacy platform
The deal signals a clear push to expand access to care in underserved regions
The Pharmaceuticals portfolio and pipeline are more promising than perhaps ever before
The investigational therapy, MDX2003, is designed to go after cancer cells with a multi-pronged immune attack
The collaboration underscores a broader industry shift toward hybrid research models that integrate computational biology with advanced experimental systems
Subscribe To Our Newsletter & Stay Updated
